Trials / Completed
CompletedNCT00230672
Investigation of Plasma Proteins in Patients With Hereditary Haemorrhagic Telangiectasia and PAVMs
Studies of Plasma Proteins Derived From Pulmonary Arteriovenous Malformation Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1 (actual)
- Sponsor
- Imperial College London · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Hereditary Haemorrhagic Telangiectasia (HHT, also known as Osler-Weber-Rendu Syndrome) is an disease that leads to the development of dilated and fragile blood vessels, including arteriovenous malformations in the lungs (PAVMs). We hypothesize that the genetically-determined abnormality in the blood vessels of HHT patients leads to alteration in the concentrations or activity of several proteins in the blood stream. We propose to take blood samples from patients at defined times in order to study changes in blood protein levels and activity
Conditions
Timeline
- Start date
- 2005-03-01
- Primary completion
- 2008-03-01
- Completion
- 2008-03-01
- First posted
- 2005-10-03
- Last updated
- 2023-09-28
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT00230672. Inclusion in this directory is not an endorsement.